USFDA issues EIR for Biocon Bengaluru facility Ruchika Sharma25 Dec 2024 12:53 PM ISTBengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and...
Aarti Drugs gets USFDA EIR for Tarapur facility Ruchika Sharma24 Dec 2024 4:22 PM ISTMumbai: Aarti Drugs Limited has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) at the end...
USFDA inspection: Aurobindo Pharma arm Telangana facility gets 2 observations Ruchika Sharma18 Dec 2024 12:30 PM ISTTelangana: Aurobindo Pharma has announced in a BSE filing that the US Food and Drug Administration (USFDA) has concluded inspection with 2...
Indoco Remedies receives warning letter from USFDA for Goa facility Ruchika Sharma17 Dec 2024 4:04 PM ISTMumbai: Indoco Remedies has received a warning letter from the US Food and Drug Administration (USFDA) for the company's Plant II & Plant III...
Biocon gets EIR with VAI status from USFDA for Bengaluru API facility Ruchika Sharma9 Dec 2024 11:30 AM ISTBangalore: In a recent BSE filing, Biocon has informed that the U.S. Food and Drug Administration (US FDA) has issued an Establishment...
Cipla gets 8 USFDA observations for Virgonagar facility Ruchika Sharma14 Nov 2024 12:01 PM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the Company's...
USFDA classifies Biocon Biologics Biocon Park Site in Bengaluru as VAI Ruchika Sharma11 Nov 2024 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' facilities at Biocon Park,...
Granules India Unit V facility receives USFDA EIR with 'No Action Indicated' status Ruchika Sharma8 Nov 2024 10:00 AM ISTHyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an Establishment Inspection Report (EIR)...
Shilpa Medicare gets four USFDA observations for Bengaluru facility Ruchika Sharma4 Nov 2024 3:58 PM ISTRaichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...
USFDA classifies Cipla Goa facility as VAI Ruchika Sharma4 Nov 2024 11:30 AM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
Sai Life Sciences receives EIRs from USFDA for India RnD, Manufacturing facilities Ruchika Sharma29 Oct 2024 12:00 PM ISTHyderabad: Sai Life Sciences, a Indian Contract Research, Development and Manufacturing Organization (CRDMO), has announced that it has...
Alembic Pharma successfully completes USFDA inspection at Panelav Oncology formulation facility Ruchika Sharma9 Oct 2024 11:20 AM ISTVadodara: Alembic Pharma has announced that the Company has successfully completed the United States Food and Drug Administration (USFDA)...
